Inventor
Kevin W. Gillman
Inventor
Madison, CT, US
Overview
Patents· 18 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds24%
A61KPreparations for medical, dental or toiletry purposes22%
C07KPeptides9%
Y02ATechnologies for adaptation to climate change5%
C07CAcyclic or carbocyclic compounds4%
Y02PClimate change mitigation technologies in the production or processing of goods4%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
C07HSugars2%
PatentTitleYear
11,066,445Immunomodulators acting as antagonists of PD-1202110,988,507Immunomodulators202110,633,419Immunomodulators202010,538,555Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions20209,856,292'Immunomodulators'20188,691,821'Oxazolidinones as modulators of mGluR5'20148,383,821'NK-1 and serotonin transporter inhibitors'20138,350,084'Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production'20138,093,276'Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production'20128,084,477'Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production'20118,071,778'Substituted heterocyclic ethers and their use in CNS disorders'20118,044,077'Alpha-(N-sulfonamido)acetamide compounds incorporating deuterium as inhibitors of beta amyloid peptide production'20117,091,202'4-arylspirocycloalkyl-2-aminopyrimidine carboxamide KCNQ potassium channel modulators'20066,930,100'Phosphate prodrugs of fluoroxindoles'20056,916,937'Carbohydrate prodrugs of fluorooxindoles'20056,096,745'Imidazolone anorectic agents: III. heteroaryl derivatives'20006,063,934'Imidazolone anorectic agents: 1. 2-substituted-3,5-dihydro-5,5-diphenyl-4H-imidazol-4-ones'20006,054,590'Imidazolone anorectic agents: II. phenyl derivatives'2000Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2000–2021Patents assigned to BRISTOL MYERS SQUIBB CO (18)· patent assignee history
2000–2021Based in Madison, CT, US· patent location history
2011–2014Patents assigned to GILLMAN KEVIN W (6)· patent assignee history
2011–2013Patents assigned to OLSON RICHARD E (3)· patent assignee history
2011–2013Patents assigned to STARRETT JR JOHN E (3)· patent assignee history
2013–2014Patents assigned to DEGNAN ANDREW P (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 18 | 2000–2021 |
| GILLMAN KEVIN Wself | 6 | 2011–2014 |
| OLSON RICHARD E | 3 | 2011–2013 |
| STARRETT JR JOHN E | 3 | 2011–2013 |
| DEGNAN ANDREW P | 2 | 2013–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Madison, CT, US | 18 | 2000–2021 |